Raid Aljumaily, MD
Hematologist/Oncologist
(48 Ratings)
, 9 Comments
VIEW ALL COMMENTS
Position:
Hematologist/Oncologist
Primary Specialty:
Hematology & Oncology
Languages Spoken:
Arabic, English
Practice Started:
1/1/2011
Gender:
Male
About Raid Aljumaily
Raid Aljumaily, MD, associate professor, Hematology/Oncology, joined the Stephenson Cancer Center in 2014. His interest in thoracic oncology started during his fellowship years at Tufts Medical Center in Boston, where he learned a broad spectrum of methods and approaches to treating thoracic malignancies. Aljumaily continues to build upon this knowledge through utmost patient care and extensive research, particularly, a phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant chemotherapy.
While in East Carolina University, he did a retrospective review of his experience treating lung cancer patients with oligometastatic disease. Dr. Aljumaily’s background inspires him to link basic science findings to clinical research ideas for patients with lung cancer.
Dr. Aljumaily is a member of the lung committee of 2 national cooperative groups (SWOG and NRG) and the chair on a national NCI sponsored clinical trial, S1933 for a novel approach to treatment of patients with stage 2 and 3 non-small cell lung cancer.
Affiliations
OU Health Stephenson Cancer Center – Thoracic Cancer Clinic,
OU Health Stephenson Cancer Center
Awards
National Institute of Health, National Cancer Institute, T32 Research Training Grant
2009
National Institute of Health, National Cancer Institute, T32 Research Training Grant
2010
National Institute of Health, National Cancer Institute, T32 Research Training Grant
2011
Oral presentation at the ECOG Young Investigator Symposium
2010
Health Education
Medical School
Baghdad University, College of Medicine
Fellowship
Hematology/Oncology
Tufts Medical Center
Internship
Internal Medicine
Drexel University College of Medicine
Residency
Internal medicine
Hahnemann University Hospital Philadelphia
Board Certification
American Board of Internal Medicine
Medical Oncology
Hematology
Medical School
Medical Degree
King Edward Medical College
Residency
Internal Medicine
Drexel University College of Medicine
Medical Interests
Areas of Interest:
Thoracic malignancies (Lung cancer) Lung and esophageal cancers Oligometastatic Disease Non-Small Cell Lung Cancer Research Interests:
Retrospective review of past experience in treating patients with non-small cell lung cancer with oligometastatic disease with curative intent Phase II study to treat patients with minimal stage VI non-small cell lung cancer with curative intent
